{"id":"NCT03069352","sponsor":"AbbVie","briefTitle":"A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy","officialTitle":"A Randomized, Double-Blind, Placebo Controlled Phase 3 Study of Venetoclax Co-Administered With Low Dose Cytarabine Versus Low Dose Cytarabine in Treatment Naïve Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-05-23","primaryCompletion":"2019-02-15","completion":"2025-07-23","firstPosted":"2017-03-03","resultsPosted":"2020-02-28","lastUpdate":"2025-08-20"},"enrollment":211,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Myeloid Leukemia (AML)"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Venetoclax","otherNames":["ABT-199","Venclexta"]},{"type":"DRUG","name":"Cytarabine","otherNames":["Cytosar-U","Ara-C","Arabinosylcytosine"]}],"arms":[{"label":"Venetoclax + Low Dose Cytarabine (LDAC)","type":"EXPERIMENTAL"},{"label":"Placebo + LDAC","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to evaluate if venetoclax when co administered with low-dose cytarabine (LDAC) improves overall survival (OS) versus LDAC and placebo, in treatment-naïve patients with acute myeloid leukemia (AML).","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From randomization until the primary analysis cut-off date of February 15 2019; the median follow-up time was 12.0 months (range: 0.2-17.0) in the placebo arm and 12.0 months (range: 0.1-17.6) in the venetoclax arm.","effectByArm":[{"arm":"Placebo + Low Dose Cytarabine (LDAC)","deltaMin":4.1,"sd":null},{"arm":"Venetoclax + Low Dose Cytarabine (LDAC)","deltaMin":7.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.114"},{"comp":"OG000 vs OG001","p":"0.103"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":109,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","China","Czechia","France","Germany","Greece","Hungary","Ireland","Japan","Mexico","New Zealand","Norway","Puerto Rico","Russia","South Africa","South Korea","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["32219442","35829925","34599139"],"seeAlso":["http://www.rxabbvie.com/"]},"adverseEventsSummary":{"seriousAny":{"events":42,"n":68},"commonTop":["THROMBOCYTOPENIA","NAUSEA","NEUTROPENIA","HYPOKALAEMIA","DIARRHOEA"]}}